HomeTOP STORIESNovartis beats Q4 top-line and bottom-line estimates; initiates FY25 soft outlook Novartis beats Q4 top-line and bottom-line estimates; initiates FY25 soft outlook By rogerjudd January 31, 2025 FacebookTwitterPinterestWhatsApp Post Content Previous articleMetsera prices IPO at $18 per shareNext articleDoug Burgum Is Confirmed by Senate as Interior Secretary latest articles The inflation process has shifted even as headline CPI declined – Federal Reserve Cerrado Gold reports Q4 results As H-1B Visa Program Changes, Skilled Foreign Workers Consider Leaving U.S. They Get Drunk Without Drinking: What It’s Like to Have Auto-brewery Syndrome Parents Who Borrowed for Children’s College Face Looming Deadline Watch: Artemis II’s journey so far… in 85 seconds explore more The inflation process has shifted even as headline CPI declined – Federal Reserve Cerrado Gold reports Q4 results As H-1B Visa Program Changes, Skilled Foreign Workers Consider Leaving U.S. They Get Drunk Without Drinking: What It’s Like to Have Auto-brewery Syndrome Parents Who Borrowed for Children’s College Face Looming Deadline Watch: Artemis II’s journey so far… in 85 seconds
